Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
Tuesday, July 08, 2025Celltrion USA today announced that STOBOCLO denosumabbmwo and OSENVELT denosumabbmwo biosimilars referencing PROLIA denosumab and XGEVA denosumab respectively are commercially available in the United States
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
Tuesday, July 08, 2025Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study NCT It will investigate the efficacy safety and tolerability of BI as a potential oral treatment to improve vision in people with diabetic macular edema DME
Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards.
Tuesday, July 08, 2025Upperton Pharma Solutions a leading Nottinghambased pharmaceutical contract development and manufacturing organisation CDMO is delighted to announce its recognition as the winner of the Business
Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan
Friday, July 04, 2025Stallergenes Greer Shionogi Co Ltdand CEOLIA Pharma Co Ltd CEOLIA today announced the transition of promotional activities for Actair in Japan Actair is Stallergenes Greers sublingual immunotherapy
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH Trial
Thursday, July 03, 2025Merck known as MSD outside of the United States and Canada today announced that the US Food and Drug Administration FDA has accepted and granted priority review for a new supplemental Biologics License Application
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
Wednesday, July 02, 2025Alvotecha global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited Advanz Pharma a UK headquartered global pharmaceutical company
ValGenesis and CAI Partner to Advance AI-Enabled Digital Validation in Life Sciences
Wednesday, July 02, 2025ValGenesis Inc the global leader in digital validation lifecycle management today announced a strategic partnership with CAI a professional services firm specializing in accelerating operational readiness in missioncritical environments
Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS
Tuesday, July 01, 2025Klotho Neurosciences Inctoday announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO its investigational gene therapy for amyotrophic lateral sclerosis ALS
Chai Discovery Unveils Chai-2 Breakthrough, Achieving Fully De Novo Antibody Design With AI
Tuesday, July 01, 2025Chai Discovery which builds frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules today announced a breakthrough in the de novo design of antibodies
